🟢 Moderna is trading 8.5% up today after a 23.55% fall on August 20

Moderna is trading at $144.62, up +8.47%, rebounding after falling 23.55% to $133.32 on August 20.

• No clear new company-specific catalyst was identified for the August 21 rebound.
• Investor interest remains elevated after Moderna and Merck reported positive Phase 3 melanoma-vaccine results on August 19.
• The broader biotech sector is weaker, suggesting today’s move is primarily a volatile, company-specific rebound rather than sector momentum.